Iplex Articles
Grants cut Insmed's 2008 loss 22%
23 March 2009
Insmed sees good Ph II IPLEX results
7 May 2007
Italy's MoH requests Insmed's Iplex for ALS treatment
15 January 2007
EMEA validates Insmed's Iplex MA
10 July 2006
Insmed updates on IPLEX launch
13 June 2006
Insmed launches Iplex in USA
29 May 2006
Insmed prices $40M equity offering
20 March 2006
Insmed shares soar on news of US OD designation for Iplex
19 December 2005
Showing 1-10 of 10 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
